GE HealthCare Technologies Inc.
GEHCHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeGE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States,. Valued at $28.69B, GEHC is a large-cap name in its sector. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
Market Cap
$28.69B
Beta
0.84
P/E (TTM)
15.77
P/E (Fwd)
11.76
EPS (TTM)
$4.00
EPS (Fwd)
$5.36
ROE
19.5%
ROA
5.2%
Cash
$2.26B
Total Debt
$10.58B
Free CF
$1.48B
52W Change
-17.0%
Annual Financials
Cash vs Debt
On the balance sheet, GEHC has $2.26B in cash with $10.58B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $1.48B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 19.5% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $18.34B to $20.62B.
As with any equity investment, GEHC carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence GE HealthCare Technologies Inc.'s trajectory.